Resistin regulates pituitary lipid metabolism and inflammation in vivo and in vitro

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Rodriguez Pacheco, F ^a,b,c   Novelle, M G ^a,b   Vazquez, M J ^a,b   Garcia Escobar, E ^c,d   Soriguer, F ^c,d   Rojo Martinez, G ^c,d   Garcia Fuentes E ^c,d   Malagon, M M ^b,e   Dieguez, C ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Hospital University Carlos Haya de Málaga   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; FATTY ACID SYNTHASE; GROWTH HORMONE; INTERLEUKIN 6; LIPOPROTEIN LIPASE; MALONYL COENZYME A DECARBOXYLASE; MESSENGER RNA; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; CARBOXYLYASE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; MALONYL-COA DECARBOXYLASE;

ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HYPOPHYSIS; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LIPOLYSIS; MALE; NONHUMAN; NUTRITIONAL STATUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ANIMAL; DRUG EFFECT; ENZYMOLOGY; GENETICS; INFLAMMATION; METABOLISM; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; DRUG EFFECTS;

ANIMALS; CARBOXY-LYASES; CARNITINE O-PALMITOYLTRANSFERASE; CELLS, CULTURED; FATTY ACID SYNTHASES; FATTY ACIDS; INFLAMMATION; INTERLEUKIN-6; LIPID METABOLISM; LIPOPROTEIN LIPASE; MALE; PITUITARY GLAND; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA; IN VITRO TECHNIQUES;

EID: 84877282285     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/479739     Document Type: Article

References (33)

1. Zhang W., Chai B., Li J. Y., Wang H., Mulholland M. W., Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology 2008 149 9 4710 4716 2-s2.0-50449085374 10.1210/en.2008-0263
2. Kovacs M., Kineman R. D., Schally A. V., Zarandi M., Groot K., Frohman L. A., Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly. Endocrinology 1997 138 11 4536 4542 2-s2.0-0030827581 10.1210/en.138.11.4536 (Pubitemid 27460884)
3. Cordoba-Chacon J., Gahete M. D., Castano J. P., Kineman R. D., Luque R. M., Homologous and heterologous in vitro regulation of pituitary receptors for somatostatin, growth hormone (GH)-releasing hormone, and ghrelin in a nonhuman primate (Papio anubis). Endocrinology 2012 153 1 264 272 10.1210/en.2011-1677
4. Brown W. J., Williams L., Ford J. H., Ball K., Dobson A. J., Identifying the energy gap: magnitude and determinants of 5-year weight gain in midage women. Obesity 2005 13 8 1431 1441
5. Wynne K., Stanley S., McGowan B., Bloom S. R., Appetite control. Journal of Endocrinology 2005 184 2 291 318 2-s2.0-14844334627 10.1677/joe.1.05866 (Pubitemid 40347231)
6. Verdich C., Flint A., Gutzwiller J. P., Näslund E., Beglinger C., Hellström P. M., Long S. J., Morgan L. M., Holst J. J., Astrup A., A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on Ad Libitum energy intake in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 9 4382 4389 2-s2.0-17944365214 10.1210/jc.86.9.4382 (Pubitemid 32848563)
7. Mojsov S., Weir G. C., Habener J. F., Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. Journal of Clinical Investigation 1987 79 2 616 619 2-s2.0-0023107555 (Pubitemid 17009701)
8. Nauck M. A., Heimesaat M. M., Orskov C., Holst J. J., Ebert R., Creutzfeldt W., Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Journal of Clinical Investigation 1993 91 1 301 307 2-s2.0-0027391607 (Pubitemid 23037285)
9. Matheeussen V., Baerts L., de Meyer G., de Keulenaer G., van der Veken P., Augustyns K., Dubois V., Scharpé S., de Meester I., Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries. Biological Chemistry 2011 392 3 189 198 2-s2.0-79953320085 10.1515/BC.2011.002
10. Nauck M. A., Bartels E., Orskov C., Ebert R., Creutzfeldt W., Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. Journal of Clinical Endocrinology and Metabolism 1993 76 4 912 917 2-s2.0-0027419106 10.1210/jc.76.4.912 (Pubitemid 23110837)
11. Drucker D. J., Philippe J., Mojsov S., Chick W. L., Habener J. F., Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proceedings of the National Academy of Sciences of the United States of America 1987 84 10 3434 3438 2-s2.0-0344357096 (Pubitemid 17085418)
12. Kjems L. L., Holst J. J., Vølund A., Madsbad S., The influence of GLP-1 on glucose-stimulated insulin secretion: Effects on β -cell sensitivity in type 2 and nondiabetic subjects. Diabetes 2003 52 2 380 386 2-s2.0-0037312821 10.2337/diabetes.52.2.380 (Pubitemid 36173193)
13. Mentis N., Vardarli I., Köthe L. D., Holst J. J., Deacon C. F., Theodorakis M., Meier J. J., Nauck M. A., GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes. Diabetes 2011 60 4 1270 1276 2-s2.0-79953165707 10.2337/db10-1332
14. Dalamaga M., Sotiropoulos G., Karmaniolas K., Pelekanos N., Papadavid E., Lekka A., Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters. Clinical Biochemistry 2013 10.1016/j.clinbiochem.2013.01.001
15. Holst J. J., Deacon C. F., Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. Diabetologia 2005 48 4 612 615 2-s2.0-17844399596 10.1007/s00125-005-1705-7 (Pubitemid 40591213)
16. Toft-Nielsen M. B., Damholt M. B., Madsbad S., Hilsted L. M., Hughes T. E., Michelsen B. K., Holst J. J., Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. Journal of Clinical Endocrinology and Metabolism 2001 86 8 3717 3723 2-s2.0-0034880655 10.1210/jc.86.8.3717 (Pubitemid 32755966)
17. Reichlin S., Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology 1961 69 225 230 2-s2.0-0008193290
18. Guillemin R., Brazeau P., Bohlen P., Esch F., Ling N., Wehrenberg W. B., Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 1982 218 4572 585 587 2-s2.0-0019936875 (Pubitemid 12003047)
19. Lee L. T. O., Siu F. K. Y., Tam J. K. V., Lau I. T. Y., Wong A. O. L., Lin M. C. M., Vaudry H., Chow B. K. C., Discovery of growth hormone-releasing hormones and receptors in nonmammalian vertebrates. Proceedings of the National Academy of Sciences of the United States of America 2007 104 7 2133 2138 2-s2.0-33847787056 10.1073/pnas.0611008104 (Pubitemid 46391364)
20. Berry S. A., Srivastava C. H., Rubin L. R., Phipps W. R., Pescovitz O. H., Growth hormone-releasing hormone-like messenger ribonucleic acid and immunoreactive peptide are present in human testis and placenta. Journal of Clinical Endocrinology and Metabolism 1992 75 1 281 284 2-s2.0-0026751096 10.1210/jc.75.1.281
21. Tomas E., Tsao T. S., Saha A. K., Murrey H. E., Zhang C. C., Itani S. I., Lodish H. F., Ruderman N. B., Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America 2002 99 25 16309 16313 2-s2.0-0037059013 10.1073/pnas.222657499 (Pubitemid 35462791)
22. Tomas E., Tsao T. S., Saha A. K., Murrey H. E., Zhang C. C., Itani S. I., Lodish H. F., Ruderman N. B., Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America 2002 99 25 16309 16313 2-s2.0-0037059013 10.1073/pnas.222657499 (Pubitemid 35462791)
23. Zakikhani M., Dowling R., Fantus I. G., Sonenberg N., Pollak M., Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Research 2006 66 21 10269 10273 2-s2.0-33751284806 10.1158/0008-5472.CAN- 06-1500 (Pubitemid 44799743)
24. Ciampani T., Fabbri A., Isidori A., Dufau M. L., Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function. Endocrinology 1992 131 6 2785 2792 2-s2.0-0026443527 10.1210/en.131.6.2785
25. Matsubara S., Sato M., Mizobuchi M., Niimi M., Takahara J., Differential gene expression of growth hormone (GH)-releasing hormone (GRH) and GRH receptor in various rat tissues. Endocrinology 1995 136 9 4147 4150 2-s2.0-0029121045
26. Kiaris H., Koutsilieris M., Kalofoutis A., Schally A. V., Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists. Expert Opinion on Investigational Drugs 2003 12 8 1385 1394 2-s2.0-0041633498 10.1517/13543784.12.8.1385 (Pubitemid 36949695)
27. Bagnato A., Moretti C., Ohnishi J., Frajese G., Catt K. J., Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary. Endocrinology 1992 130 3 1097 1102 2-s2.0-0026602528 10.1210/en.130.3. 1097
28. Lim C. T., Kola B., Korbonits M., AMPK as a mediator of hormonal signalling. Journal of Molecular Endocrinology 2010 44 2 87 97 2-s2.0-75749104187 10.1677/JME-09-0063
29. Winder W. W., Hardie D. G., Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. The American Journal of Physiology 1996 270 2 E299 E304 2-s2.0-0029978799
30. Towler M. C., Hardie D. G., AMP-activated protein kinase in metabolic control and insulin signaling. Circulation Research 2007 100 3 328 341 2-s2.0-33847080728 10.1161/01.RES.0000256090.42690.05
31. Steinberg G. R., Jørgensen S. B., The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Reviews in Medicinal Chemistry 2007 7 5 519 526 2-s2.0-34447344125
32. Locatelli V., Torsello A., Pyruvate and satiety: can we fool the brain? Endocrinology 2005 146 1 1 2 2-s2.0-11144225838 10.1210/en.2004-1336 (Pubitemid 40051713)
33. Motoshima H., Goldstein B. J., Igata M., Araki E., AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. Journal of Physiology 2006 574 1 63 71 2-s2.0-33745213627 10.1113/jphysiol.2006. 108324 (Pubitemid 43905797)